NCT00419302View on ClinicalTrials.gov

To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

April 30, 2004

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Technosphere/Insulin

Trial Locations (1)

D-41460

Profil Institute for Metabolic Research, Hellersbergstr

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY